Cargando…
Multidrug-Resistant Microbial Therapy Using Antimicrobial Peptides and the CRISPR/Cas9 System
The emergence and spread of multidrug-resistant microbes become a serious threat to animal and human health globally because of their less responsiveness to conventional antimicrobial therapy. Multidrug-resistant microbial infection poses higher morbidity and mortality rate with significant economic...
Autores principales: | Getahun, Yared Abate, Ali, Destaw Asfaw, Taye, Bihonegn Wodajnew, Alemayehu, Yismaw Alemie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379109/ https://www.ncbi.nlm.nih.gov/pubmed/35983086 http://dx.doi.org/10.2147/VMRR.S366533 |
Ejemplares similares
-
Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides
por: Cui, Yan-ru, et al.
Publicado: (2020) -
Multidrug-Resistant Enterococci Lack CRISPR-cas
por: Palmer, Kelli L., et al.
Publicado: (2010) -
Fundamental CRISPR-Cas9 tools and current applications in microbial systems
por: Tian, Pingfang, et al.
Publicado: (2017) -
Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
por: Wang, Kun, et al.
Publicado: (2019) -
What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)